Ahmed S. Qazi

Ahmed S. Qazi

Auto-generated profile, based on publicly available information

Ahmed S. Qazi

Life University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2020 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
PTPhillip D. Tomporowski
Phillip D. Tomporowski
AQAhmed S. Qazi
Ahmed S. Qazi
Bouts of exercise performed either prior to or immediately following study periods enhance encoding and learning. Empirical evidence supporting the benefits of interventions that simultaneously pair physical activity with material to be learned is not conclusive, however. A narrative, theory-based review of dual-task experiments evaluated studies in terms of arousal theories, attention theories, cognitive-energetic theories, and entrainment theories. The pattern of the results of these studies suggests that cognitive-motor interference can either impair or enhance memory of semantic information and the manner in which physical activity impacts working memory within executive processing appears to explain disparate outcomes. The integration and timing of physical movements in concert with the type of information to be encoded and remembered appears to be a critical requirement for learning. These observations have implications for the role of physical activity in education, rehabilitation, and gerontological settings.

28 March 2019 in Journal of Metabolic Health
Verified
Journal Article
Open access
PDF file
Angelia Maleah WinklerAngelia Maleah Winkler
Angelia Maleah Winkler
AQAhmed S. Qazi
Ahmed S. Qazi
KBKristen N. Beasley
Kristen N. Beasley
HBHannah R. Bennett
Hannah R. Bennett
Background: Exogenous ketone salts (KS) have been administered as treatment for various health conditions; however, the safety of chronic supplementation in a healthy population has yet to be explored.Aim: This study examined the safety of KS supplementation for 6 weeks in healthy, young adults and determined the effects of KS on blood ketone levels.Setting: Data collection occurred in a laboratory at Augusta University.Methods: Twenty-three men and women (aged 18–35 years old) supplemented with KS or a placebo (PLA) twice per day for 6 weeks in a randomised, double-blinded, PLA-controlled design. Baseline and post-intervention measures included body mass index (BMI), resting blood pressure and heart rate, questionnaires assessing mood and energy, urinalysis, and venous blood measures, including comprehensive metabolic panel (CMP), lipid panel, and complete blood count (CBC). In addition, the participants consumed the assigned supplement during the baseline and post-intervention visits; blood ketone levels were assessed immediately before and after 30 and 60 min post-supplementation.Results: Systolic blood pressure was significantly lower (p 0.05) after supplementing with KS for 6 weeks but not PLA. All other health parameters remained unchanged by KS supplementation, including BMI, resting heart rate, urinalysis, CMP, lipid panel, and CBC. After acute administration of KS but not PLA, blood ketone levels were significantly elevated (p 0.001) 30 and 60 min after supplementation at both baseline and post-intervention visits.Conclusion: Chronic KS supplementation seems safe, significantly elevates blood ketone levels 30 and 60 min after supplementation and may lower blood pressure. Future explorations should determine the success of KS supplementation as a strategy to combat hypertension.

11 November 2022 in Psychology of Sport and Exercise
Verified
Journal Article
Closed access
DSDaphne Schmid
Daphne Schmid
AQAhmed Qazi
Ahmed Qazi
NSNathan M. Scott
Nathan M. Scott
PTPhillip D. Tomporowski
Phillip D. Tomporowski

2 July 2026
Verified
Book Chapter
Closed access
PDF file
PTPhillip D. Tomporowski
Phillip D. Tomporowski
TPTyson Perez
Tyson Perez
AQAhmed S. Qazi
Ahmed S. Qazi
SSStephanie G. B. Sullivan
Stephanie G. B. Sullivan

27 March 2026 in JMIR Research Protocols
Verified
Journal Article
Open access
MSMargaret Sliwka
Margaret Sliwka
TPTyson Perez
Tyson Perez
AQAhmed Qazi
Ahmed Qazi
SSStephanie G. B. Sullivan
Stephanie G. B. Sullivan
Background: Few manual chiropractic high velocity, low amplitude (HVLA) type shams have been validated in research. The proposed project is a randomized controlled trial (RCT) designed to assess a novel, full-spine, manual sham chiropractic maneuver and its blinding success. Objective: This study aims to evaluate the blinding integrity of participants receiving a genuine or sham chiropractic maneuver. We will also be evaluating the effects of genuine chiropractic treatments relative to sham chiropractic treatments by measuring several neurophysiological mechanisms. Methods: Participants (N=60) will be recruited from in and around Marietta, Georgia, United States. They will undergo a chiropractic physical exam and health history review with a licensed chiropractor and be randomized to either a sham or genuine chiropractic group (1:1 ratio). Participants, outcome assessors, and data analysts will be blinded to group allocation. The genuine group will receive diversified HVLA chiropractic spinal manipulative therapy (SMT), while the sham group will receive a novel chiropractic HVLA-emulating therapy. Each participant will attend 2 sessions spaced 1 week apart. Assessments will consist of blinding surveys postsessions (both visits) and presession (second visit). Additionally, we will measure gait parameters. The primary outcome of interest is blinding measured via the Bang Blinding Index (Bang BI). Secondary aims include measuring blinding via the James Blinding Index (James BI) and exploring the potential differential effects of genuine versus sham SMT on gait parameters. Results: This study is being supported and internally funded by the Dr. Sid E. Williams Center for Chiropractic Research at Life University in Marietta, Georgia, United States. Our study was prospectively registered on clinicaltrials.gov (NCT06931600) on March 28, 2025, and the first participant was enrolled on May 5, 2025. As of December 10, 2025, 18 participants have completed the trial. Projections for completing data collection, data analysis, and manuscript submission are Summer 2026, Fall 2026, and Winter 2027, respectively. Conclusions: The significance of the current RCT will be in its ability to inform whether our novel, full-spine, manual sham SMT protocol successfully blinds participants, suggesting feasibility for future clinical trials, as well as assessing for secondary outcome measures between groups.